CN102145064A - 一种治疗老年性阴道炎的中药组合物及其制备方法 - Google Patents
一种治疗老年性阴道炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102145064A CN102145064A CN2011100961289A CN201110096128A CN102145064A CN 102145064 A CN102145064 A CN 102145064A CN 2011100961289 A CN2011100961289 A CN 2011100961289A CN 201110096128 A CN201110096128 A CN 201110096128A CN 102145064 A CN102145064 A CN 102145064A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- herba
- radix
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 159
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 title claims abstract description 41
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims description 34
- 244000286838 Eclipta prostrata Species 0.000 claims abstract description 7
- 238000011282 treatment Methods 0.000 claims description 52
- 229940079593 drug Drugs 0.000 claims description 50
- 210000000582 semen Anatomy 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000000843 powder Substances 0.000 claims description 22
- 244000293323 Cosmos caudatus Species 0.000 claims description 21
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 21
- 238000010438 heat treatment Methods 0.000 claims description 20
- 239000000829 suppository Substances 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 17
- 241001057584 Myrrha Species 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- 241000545442 Radix Species 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 11
- 239000006210 lotion Substances 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 10
- 239000002552 dosage form Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 241000501098 Sargentodoxa Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 241000405217 Viola <butterfly> Species 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 229960000502 poloxamer Drugs 0.000 claims description 4
- 229920001983 poloxamer Polymers 0.000 claims description 4
- 238000007493 shaping process Methods 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 239000013040 bath agent Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 235000008504 concentrate Nutrition 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000011505 plaster Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- -1 sublimed preparation Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 229940059082 douche Drugs 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 241000157835 Gardenia Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 40
- 208000003251 Pruritus Diseases 0.000 abstract description 34
- 210000001215 vagina Anatomy 0.000 abstract description 32
- 210000004877 mucosa Anatomy 0.000 abstract description 22
- 208000024891 symptom Diseases 0.000 abstract description 14
- 206010061218 Inflammation Diseases 0.000 abstract description 13
- 230000004054 inflammatory process Effects 0.000 abstract description 12
- 230000002147 killing effect Effects 0.000 abstract description 10
- 230000007803 itching Effects 0.000 abstract description 9
- 230000001076 estrogenic effect Effects 0.000 abstract description 8
- 244000045947 parasite Species 0.000 abstract description 7
- 244000111489 Gardenia augusta Species 0.000 abstract description 4
- 210000003708 urethra Anatomy 0.000 abstract description 3
- 235000011034 Rubus glaucus Nutrition 0.000 abstract description 2
- 235000009122 Rubus idaeus Nutrition 0.000 abstract description 2
- 230000009471 action Effects 0.000 abstract description 2
- 229930003944 flavone Natural products 0.000 abstract description 2
- 235000011949 flavones Nutrition 0.000 abstract description 2
- 150000004676 glycans Chemical class 0.000 abstract description 2
- 229920001282 polysaccharide Polymers 0.000 abstract description 2
- 239000005017 polysaccharide Substances 0.000 abstract description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 2
- 240000007890 Leonurus cardiaca Species 0.000 abstract 2
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 240000007651 Rubus glaucus Species 0.000 abstract 1
- 241000583586 Sagina Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000006688 Telosma cordata Species 0.000 abstract 1
- 235000017352 Telosma cordata Nutrition 0.000 abstract 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 abstract 1
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 150000002212 flavone derivatives Chemical class 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 88
- 210000004369 blood Anatomy 0.000 description 87
- 210000003734 kidney Anatomy 0.000 description 56
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 36
- 201000010099 disease Diseases 0.000 description 34
- 230000001737 promoting effect Effects 0.000 description 32
- 210000004185 liver Anatomy 0.000 description 30
- 208000002193 Pain Diseases 0.000 description 28
- 230000036407 pain Effects 0.000 description 27
- 230000007812 deficiency Effects 0.000 description 23
- 230000006870 function Effects 0.000 description 20
- 235000009508 confectionery Nutrition 0.000 description 18
- 230000002401 inhibitory effect Effects 0.000 description 18
- 231100000614 poison Toxicity 0.000 description 18
- 230000001717 pathogenic effect Effects 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 14
- 210000004209 hair Anatomy 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 206010020565 Hyperaemia Diseases 0.000 description 13
- 208000025865 Ulcer Diseases 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 239000003440 toxic substance Substances 0.000 description 13
- 239000009636 Huang Qi Substances 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 12
- 208000033809 Suppuration Diseases 0.000 description 12
- 229940011871 estrogen Drugs 0.000 description 12
- 239000000262 estrogen Substances 0.000 description 12
- 230000027939 micturition Effects 0.000 description 12
- 231100000397 ulcer Toxicity 0.000 description 12
- 206010007247 Carbuncle Diseases 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 11
- 201000001881 impotence Diseases 0.000 description 11
- 241000700199 Cavia porcellus Species 0.000 description 10
- 210000003756 cervix mucus Anatomy 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 9
- 208000009205 Tinnitus Diseases 0.000 description 9
- 208000031971 Yin Deficiency Diseases 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 231100000886 tinnitus Toxicity 0.000 description 9
- 206010003694 Atrophy Diseases 0.000 description 8
- 241000201295 Euphrasia Species 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 8
- 241000191967 Staphylococcus aureus Species 0.000 description 8
- 230000037444 atrophy Effects 0.000 description 8
- 241000411851 herbal medicine Species 0.000 description 8
- 230000009245 menopause Effects 0.000 description 8
- 206010034754 petechiae Diseases 0.000 description 8
- 230000028327 secretion Effects 0.000 description 8
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 7
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 7
- 229960003321 baicalin Drugs 0.000 description 7
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000036461 convulsion Effects 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 210000004392 genitalia Anatomy 0.000 description 7
- 238000005469 granulation Methods 0.000 description 7
- 230000003179 granulation Effects 0.000 description 7
- 230000002440 hepatic effect Effects 0.000 description 7
- 206010046901 vaginal discharge Diseases 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 206010006784 Burning sensation Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 6
- 241000588653 Neisseria Species 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 206010048245 Yellow skin Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 201000005630 leukorrhea Diseases 0.000 description 6
- 230000005906 menstruation Effects 0.000 description 6
- 231100000252 nontoxic Toxicity 0.000 description 6
- 230000003000 nontoxic effect Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 230000003014 reinforcing effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 208000008967 Enuresis Diseases 0.000 description 5
- 229920002527 Glycogen Polymers 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 241000192041 Micrococcus Species 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 229940095731 candida albicans Drugs 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000001605 fetal effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 229940096919 glycogen Drugs 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 229940023488 pill Drugs 0.000 description 5
- 230000002035 prolonged effect Effects 0.000 description 5
- 206010040872 skin infection Diseases 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 208000001387 Causalgia Diseases 0.000 description 4
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 4
- 241000475481 Nebula Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 241000588769 Proteus <enterobacteria> Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 208000012886 Vertigo Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 210000000981 epithelium Anatomy 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000004914 menses Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 206010042772 syncope Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 231100000889 vertigo Toxicity 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 206010014759 Endometrial neoplasm Diseases 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010059013 Nocturnal emission Diseases 0.000 description 3
- 208000008350 Pruritus Vulvae Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010037651 Pyometra Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 3
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 201000008275 breast carcinoma Diseases 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 201000003914 endometrial carcinoma Diseases 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 208000024756 faint Diseases 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 210000004681 ovum Anatomy 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 201000002765 pyometritis Diseases 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 238000007670 refining Methods 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000820 toxicity test Toxicity 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 210000003905 vulva Anatomy 0.000 description 3
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000007415 Anhedonia Diseases 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010061926 Purulence Diseases 0.000 description 2
- 206010040799 Skin atrophy Diseases 0.000 description 2
- 206010046914 Vaginal infection Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047531 Visual acuity reduced Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 208000019065 cervical carcinoma Diseases 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 206010014881 enterobiasis Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 230000008717 functional decline Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 239000003860 topical agent Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 238000011121 vaginal smear Methods 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001521511 Albizia kalkora Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 208000004746 Atrophic Vaginitis Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241001313288 Labia Species 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 240000003146 Lobelia chinensis Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000269978 Pleuronectiformes Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241001442514 Schistosomatidae Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000010798 Tongue disease Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 229940071110 amino-cerv Drugs 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000006067 antibiotic powder Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000011833 infective vaginitis Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000008921 jie er yin Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000008965 mitochondrial swelling Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 229940042126 oral powder Drugs 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000011120 smear test Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110096128A CN102145064B (zh) | 2011-04-18 | 2011-04-18 | 一种治疗老年性阴道炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110096128A CN102145064B (zh) | 2011-04-18 | 2011-04-18 | 一种治疗老年性阴道炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102145064A true CN102145064A (zh) | 2011-08-10 |
CN102145064B CN102145064B (zh) | 2012-09-26 |
Family
ID=44419666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110096128A Expired - Fee Related CN102145064B (zh) | 2011-04-18 | 2011-04-18 | 一种治疗老年性阴道炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102145064B (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743447A (zh) * | 2012-06-17 | 2012-10-24 | 黄俊花 | 一种治疗肾阳虚型老年性阴道炎的中药洗剂制备方法 |
CN102743595A (zh) * | 2012-06-17 | 2012-10-24 | 谷书华 | 一种治疗肾阴虚型滴虫性阴道炎的中药洗剂制备方法 |
CN102743615A (zh) * | 2012-06-17 | 2012-10-24 | 李莉 | 一种治疗发热型老年性阴道炎的中药洗剂制备方法 |
CN103330888A (zh) * | 2013-07-05 | 2013-10-02 | 陈兆文 | 用于治疗外阴瘙痒的清洗液 |
CN103417759A (zh) * | 2013-08-04 | 2013-12-04 | 夏丽华 | 一种治疗老年性阴道炎的中药制剂 |
CN103536826A (zh) * | 2013-10-18 | 2014-01-29 | 李佃场 | 一种治疗阴道炎的中药组合物及其制备方法 |
CN103611026A (zh) * | 2013-08-16 | 2014-03-05 | 吴万有 | 一种缓解阴道松弛的组合物和精华液及其制备方法 |
CN104758733A (zh) * | 2013-07-01 | 2015-07-08 | 庄兰兰 | 一种治疗老年性阴道炎的外洗剂 |
CN104815243A (zh) * | 2013-07-01 | 2015-08-05 | 刘晓晖 | 一种萎缩性阴道炎外洗液制备方法 |
CN104840802A (zh) * | 2015-06-08 | 2015-08-19 | 尚乐 | 一种治疗细菌性阴道炎的药物 |
CN105056050A (zh) * | 2015-08-28 | 2015-11-18 | 吉林大学 | 一种治疗妇科疾病的植物提取物复方栓剂及其制备方法 |
CN105456531A (zh) * | 2015-12-16 | 2016-04-06 | 韩秀敏 | 一种治疗阴虚内热型宫腔积脓的药物组合物及其制备方法 |
CN106421027A (zh) * | 2016-12-15 | 2017-02-22 | 珠海聚焦先导生物研究院有限公司 | 一种女性私处护理的中药洗液 |
USD789514S1 (en) | 2016-06-01 | 2017-06-13 | David Hill | Injectable tablet |
CN107126577A (zh) * | 2017-05-11 | 2017-09-05 | 成都欧陌商贸有限责任公司 | 一种保养子宫的卫生巾及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101049329A (zh) * | 2006-04-07 | 2007-10-10 | 刘志峰 | 当归油在升高内源性雌二醇水平,用于治疗雌二醇相关性疾病的用途 |
CN101244141A (zh) * | 2008-03-09 | 2008-08-20 | 林海 | 一种治疗轻度阴道炎症的外用中药 |
CN101569737A (zh) * | 2009-06-11 | 2009-11-04 | 杨国俊 | 一种用于妇科治疗及保健的药物及其制备方法 |
-
2011
- 2011-04-18 CN CN201110096128A patent/CN102145064B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101049329A (zh) * | 2006-04-07 | 2007-10-10 | 刘志峰 | 当归油在升高内源性雌二醇水平,用于治疗雌二醇相关性疾病的用途 |
CN101244141A (zh) * | 2008-03-09 | 2008-08-20 | 林海 | 一种治疗轻度阴道炎症的外用中药 |
CN101569737A (zh) * | 2009-06-11 | 2009-11-04 | 杨国俊 | 一种用于妇科治疗及保健的药物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
张秀珍等: "中西医结合治疗老年性阴道炎82例临床观察", 《哈尔滨医药》 * |
王灵敏: "老年性阴道炎病机和内治法探讨", 《山东中医杂志》 * |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743595A (zh) * | 2012-06-17 | 2012-10-24 | 谷书华 | 一种治疗肾阴虚型滴虫性阴道炎的中药洗剂制备方法 |
CN102743615A (zh) * | 2012-06-17 | 2012-10-24 | 李莉 | 一种治疗发热型老年性阴道炎的中药洗剂制备方法 |
CN102743447A (zh) * | 2012-06-17 | 2012-10-24 | 黄俊花 | 一种治疗肾阳虚型老年性阴道炎的中药洗剂制备方法 |
CN102743615B (zh) * | 2012-06-17 | 2013-12-11 | 任英霞 | 一种治疗发热型老年性阴道炎的中药洗剂制备方法 |
CN104815243A (zh) * | 2013-07-01 | 2015-08-05 | 刘晓晖 | 一种萎缩性阴道炎外洗液制备方法 |
CN104758733A (zh) * | 2013-07-01 | 2015-07-08 | 庄兰兰 | 一种治疗老年性阴道炎的外洗剂 |
CN103330888B (zh) * | 2013-07-05 | 2015-02-18 | 陈兆文 | 用于治疗外阴瘙痒的中药组合物及清洗液 |
CN103330888A (zh) * | 2013-07-05 | 2013-10-02 | 陈兆文 | 用于治疗外阴瘙痒的清洗液 |
CN103417759A (zh) * | 2013-08-04 | 2013-12-04 | 夏丽华 | 一种治疗老年性阴道炎的中药制剂 |
CN103417759B (zh) * | 2013-08-04 | 2015-03-04 | 夏丽华 | 一种治疗老年性阴道炎的中药制剂 |
CN103611026A (zh) * | 2013-08-16 | 2014-03-05 | 吴万有 | 一种缓解阴道松弛的组合物和精华液及其制备方法 |
CN103611026B (zh) * | 2013-08-16 | 2016-06-15 | 傅珂 | 一种缓解阴道松弛的组合物和精华液及其制备方法 |
CN103536826A (zh) * | 2013-10-18 | 2014-01-29 | 李佃场 | 一种治疗阴道炎的中药组合物及其制备方法 |
CN104840802A (zh) * | 2015-06-08 | 2015-08-19 | 尚乐 | 一种治疗细菌性阴道炎的药物 |
CN105056050A (zh) * | 2015-08-28 | 2015-11-18 | 吉林大学 | 一种治疗妇科疾病的植物提取物复方栓剂及其制备方法 |
CN105456531A (zh) * | 2015-12-16 | 2016-04-06 | 韩秀敏 | 一种治疗阴虚内热型宫腔积脓的药物组合物及其制备方法 |
USD789514S1 (en) | 2016-06-01 | 2017-06-13 | David Hill | Injectable tablet |
CN106421027A (zh) * | 2016-12-15 | 2017-02-22 | 珠海聚焦先导生物研究院有限公司 | 一种女性私处护理的中药洗液 |
CN107126577A (zh) * | 2017-05-11 | 2017-09-05 | 成都欧陌商贸有限责任公司 | 一种保养子宫的卫生巾及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102145064B (zh) | 2012-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102145064B (zh) | 一种治疗老年性阴道炎的中药组合物及其制备方法 | |
CN102145111B (zh) | 一种治疗霉菌性阴道炎的中药组合物及其制备方法 | |
CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN105343625A (zh) | 一种排毒除湿利胆的蒲公英口服液及其制备方法 | |
CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
CN103041208B (zh) | 一种治疗妇女更年期综合征的中药制剂及其制备方法 | |
CN103690919A (zh) | 用于治疗仔猪缺铁性贫血的药物及其制备方法 | |
CN102058715B (zh) | 一种治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN103800772A (zh) | 一种防治阴道炎症的妇科外用洗液及其制备方法 | |
CN105381352A (zh) | 一种治疗妇科炎症的外用中药洗液 | |
CN102988675B (zh) | 一种治疗慢性前列腺炎的中药组合物及其制备方法 | |
CN104815192A (zh) | 一种治疗高血压的药物组合物及其应用 | |
CN101433655B (zh) | 一种治疗阴道炎的中药组合物 | |
CN103041262B (zh) | 一种治疗慢性前列腺炎的中药灌肠剂及其制备方法 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN102846824B (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
CN104147538A (zh) | 一种治疗湿热毒盛型糖尿病足的中药制剂及其制备方法 | |
CN103041247A (zh) | 一种治疗阴道炎的中药栓剂及其制备方法 | |
CN103656048B (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
CN105233056A (zh) | 一种清热除湿、利胆排毒的大黄口服液及其制备方法 | |
CN106038802A (zh) | 治疗妇女卵巢早衰的中药组合物制备方法及其组合物 | |
CN106177451A (zh) | 治疗妇女卵巢早衰的中药栓剂制备方法及其栓剂 | |
CN105288315A (zh) | 一种清热除湿、利胆排毒的金钱草口服液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG WEEK TOURISM DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: LI DIANCHANG Effective date: 20130829 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266061 QINGDAO, SHANDONG PROVINCE TO: 226121 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130829 Address after: 226121 Jiangsu province Nantong markets three factory town Road No. 79 Patentee after: Nantong seven Tourism Development Co., Ltd. Address before: 1 phase 266061, Li Hai garden, Laoshan District, Shandong City, Qingdao province 12-2-402 Patentee before: Li Dianchang |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120926 Termination date: 20180418 |